Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093080
Status:
COMPLETED
Last Update Posted:
2015-02-13
First Post:
2004-09-30
Brief Title:
Study of AP23573MK-8669 Ridaforolimus A Mammalian Target of Rapamycin mTOR Inhibitor in Participants With Advanced Sarcoma MK-8669-018 AM1COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leiomyosarcoma |
| Liposarcoma |
| Osteosarcoma |
| Sarcoma Soft Tissue |
| Metastases |
Keywords:
| Name | View |
|---|---|
| Metastatic andor unresectable soft tissue or | View |